Status:
UNKNOWN
A Registry Study on Shuxuetong (a Chinese Medicine Injection) Used in Twenty Hospitals
Lead Sponsor:
China Academy of Chinese Medical Sciences
Collaborating Sponsors:
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Conditions:
Ischemic Stroke
Eligibility:
All Genders
Brief Summary
The purpose of this study is to make a cohort event monitoring to see whether and how Shuxuetong injection in hospital results in adverse events or adverse drug reactions.
Detailed Description
This is the first academic registry study about adverse events or adverse drug reaction for Chinese medicine injection in mainland China. It is well known that Chinese medicine injection is just limi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- all inpatients use Shuxuetong injection in 20 selected hospitals during their hospital stay
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT01508403
Start Date
January 1 2012
End Date
December 1 2015
Last Update
May 14 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China, 100700